T, L., I, M., N, W., C, S., A, P., T, T., . . . G, O. (2026). Tenascin-C orchestrates radiotherapy-induced head and neck tumor regression. EMBO molecular medicine, 18(5), 1707. https://doi.org/10.1038/s44321-026-00406-8
Chicago Style (17th ed.) CitationT, Loustau, et al. "Tenascin-C Orchestrates Radiotherapy-induced Head and Neck Tumor Regression." EMBO Molecular Medicine 18, no. 5 (2026): 1707. https://doi.org/10.1038/s44321-026-00406-8.
MLA (9th ed.) CitationT, Loustau, et al. "Tenascin-C Orchestrates Radiotherapy-induced Head and Neck Tumor Regression." EMBO Molecular Medicine, vol. 18, no. 5, 2026, p. 1707, https://doi.org/10.1038/s44321-026-00406-8.
Warning: These citations may not always be 100% accurate.